Yooyoung Pharmaceutical's chronic constipation treatment Rucalo(Prucalopride Succinate) 1mg and 2mg were included in the price volume agreement monitoring. Pfizer Korea's Xeljanz (Tofacitinib Citrate) 5-10mg, Novartis Korea's Revolade (Eltrombopag) 25-50mg also decreases in price due to drug price negotiations as the usage increases.

The NHIS recently unveiled the drugs subject to monitoring in the second quarter of 2021 price volume agreement negotiations (Type Ka and Na) on the website. The targets for monitoring in the second quarter of this year are 187 items in 89 drug groups.

The price volume agreement negotiation system is a method in which the NHIS and pharmaceutical companies sha